Literature DB >> 27101732

Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment.

Hanne Dorthe Emborg1, Tyra Grove Krause, Lene Nielsen, Marianne Kragh Thomsen, Claus Bohn Christiansen, Marianne Nielsine Skov, Xiaohui Chen Nielsen, Lenette Sandborg Weinreich, Thea Kølsen Fischer, Jesper Rønn, Ramona Trebbien.   

Abstract

In Denmark, both influenza A(H1N1)pdm09 and influenza B co-circulated in the 2015/16 season. We estimated the vaccine effectiveness (VE) of the trivalent influenza vaccine in patients 65 years and older using the test-negative case-control design. The adjusted VE against influenza A(H1N1)pdm09 was 35.0% (95% confidence interval (CI): 11.1-52.4) and against influenza B 4.1% (95% CI: -22.0 to 24.7). The majority of influenza A(H1N1)pdm09 circulating in 2015/16 belonged to the new genetic subgroup subclade 6B.1.

Entities:  

Keywords:  antigenic characterization; genetic drift; phylogeny; seasonal influenza; vaccine effectiveness

Mesh：

Substances：

Year:  2016        PMID： 27101732     DOI： 10.2807/1560-7917.ES.2016.21.14.30189

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  12 in total

1.  The effect of sex on responses to influenza vaccines.

Authors:  Lucy Denly
Journal:  Hum Vaccin Immunother       Date:  2020-11-12       Impact factor: 3.452

2.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

Review 3.  A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.

Authors:  Riju Ray; Gaël Dos Santos; Philip O Buck; Carine Claeys; Gonçalo Matias; Bruce L Innis; Rafik Bekkat-Berkani
Journal:  Hum Vaccin Immunother       Date:  2017-05-22       Impact factor: 3.452

4.  2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.

Authors:  Esther Kissling; Marta Valenciano; Francisco Pozo; Ana-Maria Vilcu; Annicka Reuss; Caterina Rizzo; Amparo Larrauri; Judit Krisztina Horváth; Mia Brytting; Lisa Domegan; Monika Korczyńska; Adam Meijer; Ausenda Machado; Alina Ivanciuc; Vesna Višekruna Vučina; Sylvie van der Werf; Brunhilde Schweiger; Antonino Bella; Alin Gherasim; Annamária Ferenczi; Katherina Zakikhany; Joan O Donnell; Iwona Paradowska-Stankiewicz; Frederika Dijkstra; Raquel Guiomar; Mihaela Lazar; Sanja Kurečić Filipović; Kari Johansen; Alain Moren
Journal:  Influenza Other Respir Viruses       Date:  2018-03-14       Impact factor: 4.380

5.  Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.

Authors:  Esther Kissling; Angela Rose; Hanne-Dorthe Emborg; Alin Gherasim; Richard Pebody; Francisco Pozo; Ramona Trebbien; Clara Mazagatos; Heather Whitaker; Marta Valenciano
Journal:  Euro Surveill       Date:  2019-02

6.  Novel influenza A(H1N2) seasonal reassortant identified in a patient sample, Sweden, January 2019.

Authors:  Åsa Wiman; Theresa Enkirch; AnnaSara Carnahan; Blenda Böttiger; Tove Samuelsson Hagey; Per Hagstam; Rosmarie Fält; Mia Brytting
Journal:  Euro Surveill       Date:  2019-02

7.  Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.

Authors:  Peter Bager; Jan Wohlfahrt; Jannik Fonager; Morten Rasmussen; Mads Albertsen; Thomas Yssing Michaelsen; Camilla Holten Møller; Steen Ethelberg; Rebecca Legarth; Mia Sarah Fischer Button; Sophie Gubbels; Marianne Voldstedlund; Kåre Mølbak; Robert Leo Skov; Anders Fomsgaard; Tyra Grove Krause
Journal:  Lancet Infect Dis       Date:  2021-06-22       Impact factor: 25.071

8.  Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza in 2015-2016: a hospital-based test-negative case-control study in Lithuania.

Authors:  Monika Kuliese; Ligita Jancoriene; Rita Grimalauskaite; Birute Zablockiene; Gyte Damuleviciene; Daiva Velyvyte; Vita Lesauskaite; Arvydas Ambrozaitis; Aukse Mickiene; Giedre Gefenaite
Journal:  BMJ Open       Date:  2017-10-10       Impact factor: 2.692

9.  Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies.

Authors:  Marc Rondy; Esther Kissling; Hanne-Dorthe Emborg; Alin Gherasim; Richard Pebody; Ramona Trebbien; Francisco Pozo; Amparo Larrauri; Jim McMenamin; Marta Valenciano
Journal:  Euro Surveill       Date:  2018-03

10.  Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.

Authors:  Angela Rose; Esther Kissling; Hanne-Dorthe Emborg; Amparo Larrauri; Jim McMenamin; Francisco Pozo; Ramona Trebbien; Clara Mazagatos; Heather Whitaker; Marta Valenciano
Journal:  Euro Surveill       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.